Registry for patients with acute myocarditis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The AMPHIBIA study is an observational cohort that aims to describe the various characteristics of patients hospitalized for acute myocarditis and evaluate their association with long-term prognosis. It will analyze clinical, biological, imaging, genetic, and histological data from up to 1,400 patients over a 20-year period. This comprehensive registry will provide valuable insights into the disease's progression and outcomes, helping to improve understanding and management of acute myocarditis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Acute myocarditis confirmed by cardiac magnetic resonance according to Lake Louise modified criteria or by endomyocardial biopsy according to histologic, immunologic and immunohistochemic criteria.
* affiliation to the French Health Care System "Sécurité sociale"

Exclusion Criteria:

* Severe valvulopathy
* Complex congenital cardiopathy
* Previous heart transplant
* Known significative coronary disease

Where it's running

• Hôpital Pitié-Salpêtrière
  Paris, France Recruiting

Study contacts

• Study coordinator: Mathieu Kerneis, MD
• Email: mathieu.kerneis@aphp.fr
• Phone: +33142163001

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Multimodal Cardiac MRI to See How the Heart Is Working

  This study tests a comprehensive MRI approach to characterize heart structure and tissue in adults with suspected or confirmed cardiovascular disease.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07617844

• Routine versus provisional distal perfusion catheter placement during mechanical circulatory support

  This study tests whether placing a distal perfusion catheter routinely or only provisionally improves limb outcomes in patients needing femoral artery support for mechanical circulatory support.

  Recruiting Samsung Medical Center · Changwon and 5 other locations · NCT07482865

• T1 mapping to characterize heart tissue in common heart diseases

  This project tests whether T1 mapping MRI scans, including dye-free native T1, can define normal and disease-specific heart tissue values for adults with various heart conditions.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing, Beijing Municipality · NCT07354646

• Using a myocarditis panel to guide treatment in children

  This will test whether using a combined viral genome, bacterial serology, and inflammation panel to guide treatment helps children under 18 with myocarditis who have arrhythmias or reduced heart function.

  Recruiting Azienda Ospedaliero, Universitaria Ospedali Riuniti · Ancona, The Marches · NCT07086144

• Imaging in Inflammatory Heart Diseases linked to autoimmune disorders

  This study tests how well multimodality imaging (CMR, echocardiography, and PET) detects inflammation in people with suspected inflammatory heart or autoimmune rheumatic diseases.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07077304

• Assessing genetic testing's role in arrhythmic myocarditis

  This study is testing how genetic testing can help people with myocarditis and heart rhythm problems by finding specific gene changes that might affect their condition.

  Recruiting Scientific Institute San Raffaele · Milan, Italy/Milan · NCT06889662

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.